No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
HK Stock MarketDetailed Quotes
02252 MEDBOT-B
- 11.700
- -0.460-3.78%
Noon Break Apr 19 12:00 CST
11.22BMarket Cap-10042P/E (TTM)
11.960High11.560Low181.00KVolume11.740Open12.160Pre Close2.12MTurnover0.02%Turnover RatioLossP/E (Static)958.59MShares26.00052wk High19.57P/B11.14BFloat Cap9.68052wk Low--Dividend TTM951.99MShs Float73.450Historical High--Dividend LFY3.29%Amplitude9.680Historical Low11.689Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
MEDBOT-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Changes in Hong Kong stocks | Medical device stocks rose higher in the afternoon, and mining affected the industry's high-value consumables business growth expectations this year generally improved
Medical device stocks rose in the afternoon. As of press release, Weigao shares (01066) rose 9.25% to HK$5.08; Elken Healthcare (01,789) rose 4.35% to HK$4.08; and minimally invasive robot-B (02252) rose 1.91% to HK$13.88.
Minimally Invasive Robot-B (02252.HK) plans to hold a board meeting on March 27 to consider and approve the annual results
Gelonghui March 15 | Minimally Invasive Robot-B (02252.HK) announced that the company will hold a board meeting on March 27, 2024 (Wednesday) to consider and approve, including the Group's annual results for the year ended December 31, 2023, the proposed final dividend (if any), and other matters.
MEDBOT-B: DATE OF BOARD MEETING
Guojin Securities: Medical equipment updates are expected to accelerate demand for high-end innovative medical equipment is expected to be released
It is recommended to focus on segments such as surgical robotics, endoscopes, ultrasound, and ICU equipment.
Hong Kong Stock Concept Tracking | Policies Promote Large-scale Equipment Renewal Agencies to Pay Attention to Medical Equipment Procurement Needs (with concept stocks)
On March 1, the Executive Meeting of the State Council reviewed and approved the “Action Plan to Promote Large-scale Equipment Renewal and Trade-in of Consumer Goods”, which proposed “promoting the orderly upgrading of equipment, transportation equipment, and old agricultural machinery, education and medical equipment in key industries.” The equipment update focuses on the field of “building diplomatic relations between workers and agriculture, education, culture and medicine”. The investment scale was about 6 trillion yuan in '27, with an additional investment of about 300 billion dollars every year, focusing on key industries such as metals, chemicals, building materials, electricity, machinery, transportation, textiles, and electronics. Financial support includes subsidies, tax incentives, and reloan interest rates. According to “Chinese Medical Devices
Comments
$MEDBOT-B(02252.HK$
Finally on, but did not hit a new subscription. The market is not friendly to unprofitable start-ups, and expect a more comfortable price. Kingsley bio and minimally invasive robotics are the most focused directions for innovative drugs and innovative medical devices in the future. It is nothing more than the time and rhythm of the completion of the warehouse.
Finally on, but did not hit a new subscription. The market is not friendly to unprofitable start-ups, and expect a more comfortable price. Kingsley bio and minimally invasive robotics are the most focused directions for innovative drugs and innovative medical devices in the future. It is nothing more than the time and rhythm of the completion of the warehouse.
2
$MEDBOT-B(02252.HK$
The big Four are 10 years ahead of their time in technology, waiting for the world to catch up, and they have their own medical robots. Da Vinci launched its products in 2000 based on the underlying technology of the robot industry. The more cases there are, the more powerful they are.
The big Four are 10 years ahead of their time in technology, waiting for the world to catch up, and they have their own medical robots. Da Vinci launched its products in 2000 based on the underlying technology of the robot industry. The more cases there are, the more powerful they are.
2
$MEDBOT-B(02252.HK$ Personal View of minimally invasive robot
Several key points, not profitable, High ling IPO increase, JPMORGAN Chase sponsor, expected 50% callback, IPO for the previous investment rise range is still ok, speculation new mood has not recovered;
In summary, in terms of playing new, the probability of winning is almost 50/50, the odds are not high, if the call back to break the resistance to save slightly bigger
Several key points, not profitable, High ling IPO increase, JPMORGAN Chase sponsor, expected 50% callback, IPO for the previous investment rise range is still ok, speculation new mood has not recovered;
In summary, in terms of playing new, the probability of winning is almost 50/50, the odds are not high, if the call back to break the resistance to save slightly bigger
2
$MEDBOT-B(02252.HK$ Make money on short-term market sentiment. Since we are only new, we need to have a clear positioning, just to make money in the dark market or the first two days of the listing. So, listed the first time is up or down for us is the most important! Even if you think that the future of this new stock must be bright, the future must be a big bull, and we hit the new is not related to, because we can not wait for the distant future.
1
Read more
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg